Riboflavin - Generic Drug Details
✉ Email this page to a colleague
US Patents and Regulatory Information for riboflavin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaukos | EPIOXA HD/EPIOXA KIT | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 219910-001 | Oct 17, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaukos | PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
